CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Youngki Lee, Cheol Ryong Ku, Eui-Hyun Kim, Jae Won Hong, Eun Jig Lee, Sun Ho Kim
Endocrinol Metab. 2014;29(3):280-292.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.280

Excel Download

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Endocrinology and Metabolism. 2014;29(3):280   Crossref logo
Link1 Link2 Link3

Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas
Clinical Endocrinology. 2000;53(5):595-599   Crossref logo
Link1 Link2 Link3

Long-term results of cabergoline therapy for macroprolactinomas and analyses of factors associated with remission after withdrawal
Clinical Endocrinology. 2016;86(2):207-213   Crossref logo
Link1 Link2 Link3

Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients
Yearbook of Endocrinology. 2010;2010:345-346   Crossref logo
Link1 Link2

Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas
Journal of the Endocrine Society. 2017;1(3):221-230   Crossref logo
Link1

Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas
Yearbook of Endocrinology. 2009;2009:278-279   Crossref logo
Link1 Link2

Early intervention in parkinson’s disease with cabergoline – Results of an open-label long-term trial with focus on sleep disturbances
Clinical Neurophysiology. 2007;118(4):e53   Crossref logo
Link1 Link2

Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated
Endocrine. 2020;72(1):216-222   Crossref logo
Link1 Link2 Link3

Cabergoline treatment of pregnant women with macroprolactinomas
International Journal of Gynecology & Obstetrics. 2007;99(1):61-62   Crossref logo
Link1 Link2 Link3 Link4 Link5

Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists
European Journal of Internal Medicine. 2009;20(4):387-393   Crossref logo
Link1 Link2